All Type of News


Things that will change if identifier codes of pharmaceutical products are applied

Ifthe identifier coderegulation on pharmaceutical products is actively enforced, it seems that pharmaceutical distribution companies should have a different way to report supply transactions to the existing one. Rece...

The pharmaceutical industry concerns about expansion of the pharmaceutical electronic commerce

As the pharmaceutical electronic commerce has been spread, a part of the pharmaceutical distribution industry has startedto concern about the trend. The distribution industry stated that the trend not only weakens ma...

“Pfizer Korea, tried to illegally lobby, needs to get thoroughly inspected”

It is noticed that the Health Insurance Review & Assessment Service (HIRA) stood by and watch Pfizer Korea make illegal lobbying to the Price Evaluation Committee. The Health Insurance Subscribers’Forum, on the 4th, ...

Korea Biochem Pharm has passed the actual inspection of TEVA on component manufacturing facilities

Korea Biochem Pharm, a branch of Korea United Pharm (president Duk-young Kang), has passed an actual inspection of TEVA on manufacturing facilities. As making a contract with an Israel global pharmaceutical company, ...

Multinational pharmaceutical companies’ partnerships with domestic companies… what are advantages?

Product cooperation has been widely spread between multinational pharmaceutical companies and domestic pharmaceutical companies in Korea. The partnership has generated an effect of cutting off competition as well as n...

The start-up plantoenter the top fifth in the clinical trial market worth of KRW 72 trillion

The Korea National Enterprise for Clinical Trials (chairman Dong-hyunJi, KoNECT) will push ahead with a project to accomplish its vision for the ‘Top Fifth on Clinical Trials by 2020’. The KoNECTannounced the new vis...

Cashable assets owned by listed pharmaceutical companies are worth of about KRW 1.2 trillion

It is observed that cash and cashable assets owned by listed pharmaceutical companies exceeded KRW 1.2 trillion. According to the YakupDotCom’s (www.yakup.com) analysis resultof cash and cashable assets owned by 55 l...

The pharmaceutical industry questioned effectiveness of the ‘Complementary Measures of the Pharmaceutical Industry Nurturing’

Although the Ministry of Health and Welfare released complementary measures to nurture the pharmaceuticalindustry, the industry directly involved has shown a lukewarm attitude. The Korea Pharmaceutical Manufacturers ...

The budget of the Ministry of Health and Welfare is finalized at KRW 53.4725 trillion

The 2015 budget of the Ministry of Health and Welfare is finalized at KRW 53.4725 trillion, which makes KRW 6.573 trillion compared to the last year with KRW 46.8995 trillion. According to the ‘Ministry of Health and...

The Korean pharmaceutical companies’ film-type technology interesting multinational pharmaceutical companies

Film-type technologies developed by domestic pharmaceutical companies in Korea have receivedattention from multinational pharmaceutical companies. The two pharmaceutical companies distinguished in the film-type develo...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.